Found: 15
Select item for more details and to access through your institution.
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study.
- Published in:
- Cancer Communications, 2021, v. 41, n. 2, p. 171, doi. 10.1002/cac2.12135
- By:
- Publication type:
- Article
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 513, doi. 10.4143/crt.2023.786
- By:
- Publication type:
- Article
An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer.
- Published in:
- International Journal of Women's Health, 2021, v. 13, p. 1053, doi. 10.2147/IJWH.S334756
- By:
- Publication type:
- Article
Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 3463, doi. 10.2147/DDDT.S314723
- By:
- Publication type:
- Article
High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921993436
- By:
- Publication type:
- Article
Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1439, doi. 10.1634/theoncologist.2020-0364
- By:
- Publication type:
- Article
The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
- Published in:
- Disease Markers, 2017, p. 1, doi. 10.1155/2017/6570808
- By:
- Publication type:
- Article
High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1359, doi. 10.1002/cam4.1906
- By:
- Publication type:
- Article
High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921993436
- By:
- Publication type:
- Article
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (SYSUCC-005).
- Published in:
- 2022
- By:
- Publication type:
- journal article
What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13019, doi. 10.1002/cam4.5976
- By:
- Publication type:
- Article
Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.
- Published in:
- Journal of Oncology, 2022, v. 2022, p. 1, doi. 10.1155/2022/7839041
- By:
- Publication type:
- Article
Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00646-2
- By:
- Publication type:
- Article
Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0133469
- By:
- Publication type:
- Article